Stock Markets January 30, 2026

AMD Shares Slip After Reports of MI450-Series Delays; Analyst Pushes Back

Wells Fargo says development on TSMC N2 node remains on schedule; earnings call expected to clarify launch timing

By Marcus Reed AMD
AMD Shares Slip After Reports of MI450-Series Delays; Analyst Pushes Back
AMD

Advanced Micro Devices shares dropped Friday amid reports the company’s next-generation MI450-series AI accelerators could be delayed. The decline reached as much as 6% before trimming losses to about 3% after a Wells Fargo analyst disputed the delay claims and pointed to evidence that development on TSMC’s N2 (2nm) process remains on track.

Key Points

  • AMD shares fell intraday by as much as 6% before trimming losses to around 3% amid reports of MI450-series delays.
  • Wells Fargo analyst Aaron Rakers disputed the delay claims, noting AMD has completed tape-out and shipped Venice EPYC samples using TSMC’s N2 (2nm) node.
  • AMD has previously indicated volume production of the MI450-series would begin in the second half of 2026, with sizable shipments targeted for Q4 2026 to customers including OpenAI and Oracle - this development affects semiconductor, cloud services, and data center hardware markets.

Advanced Micro Devices Inc. (NASDAQ:AMD) saw its stock fall Friday following reports that the company’s MI450-series AI accelerators may be running behind schedule. Early intraday trading showed declines of up to 6%, though losses were later reduced to roughly 3%.

Initial coverage attributing the potential delay was reported by SemiAnalysis. Those assertions were quickly challenged by Wells Fargo analyst Aaron Rakers, who said his team’s work does not support the suggestion the MI450 program is behind schedule.

Rakers told investors that AMD’s work on TSMC’s N2 (2nm) process node remains on track. He cited completed tape-out activity and the shipment of Venice EPYC processor samples that use the same N2 process node as the planned MI450-series accelerators. The analyst emphasized the importance of the N2 node to AMD’s next-generation AI accelerator roadmap.

Wells Fargo expects AMD to restate its confidence in the MI450-series timing during the company’s upcoming quarterly earnings report next week. AMD has previously signaled that volume production of the MI450-series is planned to start in the second half of 2026, with the bulk of shipments expected in the fourth quarter of 2026 to customers that include OpenAI and Oracle.

Despite the stock pullback on Friday, Rakers remained constructive on AMD’s outlook, describing the market reaction as a potential buying opportunity. He continues to forecast strong server business results, expecting AMD to report server revenue above $38 billion, and reiterated the company’s stated path toward exceeding $35 billion in data center GPU revenue by 2027.


Context on analysis services mentioned

The article previously referenced AI-driven stock selection services that review companies across financial metrics. That content described tools which evaluate firms monthly and highlighted examples of previous notable returns on some selected names. The inclusion of those service descriptions does not change the factual account of AMD’s stock movement or the analyst commentary outlined above.

Risks

  • Uncertainty over the MI450-series timing - if delays materialize, supply schedules for AI accelerators and shipments to major customers could be disrupted, impacting semiconductor and cloud infrastructure sectors.
  • Market sensitivity to reports and rumors - short-term stock volatility may be triggered by unverified claims, affecting investor sentiment in chipmakers and related tech equities.
  • Dependence on TSMC’s N2 process - any setbacks at the foundry node level could influence AMD’s product roadmap and the broader data center GPU supply chain.

More from Stock Markets

Draganfly Shares Jump After Win to Supply Flex FPV Drones and Training to Air Force Special Ops Feb 2, 2026 Peakstone Realty Trust to Be Taken Private by Brookfield; Shares Jump 33% Feb 2, 2026 Beyond Inc. Moves to Build Unified Investment and Personal Finance Platform with Tokens.com Deal Feb 2, 2026 Eton Pharmaceuticals Gains After Securing U.S. Rights to Ultra-Rare Disease Candidate Feb 2, 2026 Morgan Stanley Survey: Broader Consumer Sentiment Improves While Electronics Spending Intentions Slip Feb 2, 2026